Geratherm Medical AG (GME.DE)
EUR 3.72
(2.76%)
EUR 3.72
(2.76%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.21 Million EUR | 22.31% |
| 2022 | 1.38 Million EUR | 135.16% |
| 2021 | 589.72 Thousand EUR | -80.6% |
| 2020 | 3.03 Million EUR | 189.71% |
| 2019 | 1.04 Million EUR | -47.2% |
| 2018 | 1.98 Million EUR | 216.91% |
| 2017 | 626.99 Thousand EUR | -75.3% |
| 2016 | 2.53 Million EUR | 0.2% |
| 2015 | 2.53 Million EUR | 4.9% |
| 2014 | 2.41 Million EUR | 204.41% |
| 2013 | 793.4 Thousand EUR | -17.09% |
| 2012 | 956.94 Thousand EUR | -44.36% |
| 2011 | 1.72 Million EUR | -26.81% |
| 2010 | 2.35 Million EUR | 5.04% |
| 2009 | 2.23 Million EUR | 276.61% |
| 2008 | 594.1 Thousand EUR | -3.64% |
| 2007 | 616.55 Thousand EUR | -6.31% |
| 2006 | 658.1 Thousand EUR | 6.65% |
| 2005 | 617.08 Thousand EUR | -40.21% |
| 2004 | 1.03 Million EUR | 34.31% |
| 2003 | 768.46 Thousand EUR | -0.94% |
| 2002 | 775.75 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | 591.1 Thousand EUR | 0.0% |
| 2023 Q1 | 591.1 Thousand EUR | -29.11% |
| 2023 FY | 1.69 Million EUR | 22.31% |
| 2023 Q4 | 518.5 Thousand EUR | 0.0% |
| 2023 Q3 | 518.5 Thousand EUR | -12.28% |
| 2022 Q2 | 323.13 Thousand EUR | -54.95% |
| 2022 Q1 | 717.31 Thousand EUR | 162.25% |
| 2022 FY | 1.38 Million EUR | 135.16% |
| 2022 Q4 | 833.86 Thousand EUR | 144.65% |
| 2022 Q3 | 340.83 Thousand EUR | 5.48% |
| 2021 Q2 | 305.78 Thousand EUR | -54.75% |
| 2021 Q1 | 675.77 Thousand EUR | -24.88% |
| 2021 Q4 | -1.15 Million EUR | -251.52% |
| 2021 Q3 | 760.55 Thousand EUR | 148.73% |
| 2021 FY | 589.72 Thousand EUR | -80.6% |
| 2020 Q1 | 371.78 Thousand EUR | 288.31% |
| 2020 Q2 | 1.08 Million EUR | 190.96% |
| 2020 Q3 | 686.07 Thousand EUR | -36.58% |
| 2020 Q4 | 899.63 Thousand EUR | 31.13% |
| 2020 FY | 3.03 Million EUR | 189.71% |
| 2019 FY | 1.04 Million EUR | -47.2% |
| 2019 Q4 | -197.43 Thousand EUR | -165.01% |
| 2019 Q1 | 956.91 Thousand EUR | 32.18% |
| 2019 Q3 | 303.67 Thousand EUR | 2055.43% |
| 2019 Q2 | 14.08 Thousand EUR | -98.53% |
| 2018 Q3 | 111.94 Thousand EUR | -81.15% |
| 2018 FY | 1.98 Million EUR | 216.91% |
| 2018 Q1 | 557.43 Thousand EUR | 152.1% |
| 2018 Q2 | 593.72 Thousand EUR | 6.51% |
| 2018 Q4 | 723.93 Thousand EUR | 546.71% |
| 2017 Q4 | -1.06 Million EUR | -311.7% |
| 2017 Q3 | 505.37 Thousand EUR | 169.29% |
| 2017 FY | 626.99 Thousand EUR | -75.3% |
| 2017 Q2 | 187.67 Thousand EUR | -81.3% |
| 2017 Q1 | 1 Million EUR | 47.63% |
| 2016 Q3 | 310.68 Thousand EUR | -71.87% |
| 2016 Q1 | 443.62 Thousand EUR | 0.11% |
| 2016 FY | 2.53 Million EUR | 0.2% |
| 2016 Q4 | 679.99 Thousand EUR | 118.87% |
| 2016 Q2 | 1.1 Million EUR | 148.97% |
| 2015 FY | 2.53 Million EUR | 4.9% |
| 2015 Q4 | 443.13 Thousand EUR | -27.5% |
| 2015 Q3 | 611.25 Thousand EUR | -19.58% |
| 2015 Q2 | 760.09 Thousand EUR | 5.69% |
| 2015 Q1 | 719.15 Thousand EUR | 2.12% |
| 2014 Q3 | 645.92 Thousand EUR | -10.16% |
| 2014 Q4 | 704.22 Thousand EUR | 9.03% |
| 2014 Q2 | 718.99 Thousand EUR | 107.78% |
| 2014 Q1 | 346.03 Thousand EUR | 1033.05% |
| 2014 FY | 2.41 Million EUR | 204.41% |
| 2013 Q4 | 30.54 Thousand EUR | -81.0% |
| 2013 Q3 | 160.75 Thousand EUR | -10.7% |
| 2013 Q2 | 180.01 Thousand EUR | -57.35% |
| 2013 Q1 | 422.09 Thousand EUR | -48.62% |
| 2013 FY | 793.4 Thousand EUR | -17.09% |
| 2012 Q3 | -37.29 Thousand EUR | -251.68% |
| 2012 Q4 | 821.5 Thousand EUR | 2302.77% |
| 2012 FY | 956.94 Thousand EUR | -44.36% |
| 2012 Q1 | 148.15 Thousand EUR | -47.91% |
| 2012 Q2 | 24.58 Thousand EUR | -83.4% |
| 2011 Q4 | 284.42 Thousand EUR | -43.74% |
| 2011 Q3 | 505.58 Thousand EUR | 51.87% |
| 2011 Q1 | 597.11 Thousand EUR | -94.51% |
| 2011 FY | 1.72 Million EUR | -26.81% |
| 2011 Q2 | 332.89 Thousand EUR | -44.25% |
| 2010 FY | 2.35 Million EUR | 5.04% |
| 2010 Q4 | 10.86 Million EUR | 1635.23% |
| 2010 Q3 | 626.28 Thousand EUR | -11.45% |
| 2010 Q2 | 707.28 Thousand EUR | 28.8% |
| 2010 Q1 | 549.14 Thousand EUR | -21.7% |
| 2009 Q2 | 463.95 Thousand EUR | -7.19% |
| 2009 Q1 | 499.88 Thousand EUR | 0.0% |
| 2009 Q3 | 604.29 Thousand EUR | 30.25% |
| 2009 FY | 2.23 Million EUR | 276.61% |
| 2009 Q4 | 701.37 Thousand EUR | 16.07% |
| 2008 FY | 594.1 Thousand EUR | -3.64% |
| 2008 Q2 | 150.81 Thousand EUR | 0.0% |
| 2007 FY | 616.55 Thousand EUR | -6.31% |
| 2006 FY | 658.1 Thousand EUR | 6.65% |
| 2005 FY | 617.08 Thousand EUR | -40.21% |
| 2004 FY | 1.03 Million EUR | 34.31% |
| 2003 FY | 768.46 Thousand EUR | -0.94% |
| 2002 FY | 775.75 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| aap Implantate AG | -5.16 Million EUR | 142.933% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 98.704% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 98.704% |
| elexxion AG | -417.66 Thousand EUR | 631.344% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 46.99 Million EUR | 95.278% |
| Koninklijke Philips N.V. | -115 Million EUR | 101.93% |
| Stratec SE | 22.88 Million EUR | 90.304% |
| Siemens Healthineers AG | 2.86 Billion EUR | 99.923% |